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Emily L. Mueller1,2*, Kelly J. Walkovich3, Rajen Mody3, Achamyeleh Gebremariam4 and Matthew M. Davis4,5,6,7Correction
After publication of the original article [1] the authors
found that the following errors had occurred:
1. There was an error in the ICD-9-CM coding present in
the manuscript. Specifically, the variable for “decreased
white blood cell count” was incorrectly coded. The
“decreased white blood cell count” variable accounted
for a small proportion of the total population studied.
There were only 11 fewer patients in the final fever and
neutropenia population.* C
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UnReanalyzing the data using the corrected ICD-9-CM
codes yielded nearly identical results to those found
in the original manuscript. None of the slight
changes to odds ratios and p-values changed the
inferences of the results, except for overall charges
for short length of stay (3 days or less) discharges
decreased from $65.5 to $60.5 million US dollars.
The affected values in Tables 1, 2 and 3 from the
original manuscript have been amended to reflect
these small changes to estimates and p-values and
are included in this Correction.
2. The original manuscript includes an incorrect version
of Table 4. The estimates presented in the results
section of the manuscript are accurate, as is the
discussion of these results throughout the text and
abstract. The revised Table 4 is included in this
Correction and has also been adjusted to take into
account the above-mentioned error in coding.orrespondence: elmuelle@iupui.edu
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Table 1 Characteristics of Discharges for Non-Transferred
Pediatric Cancer Patients: Overall and for Fever and Neutropenia
(FN) Discharges – United States, 2009
Proportion of Overall
Pediatric Cancer
Discharges
Proportion of
Pediatric FN
Discharges
% (95% CI)
Patient Characteristics
Gender
Female 45.0 (44.2–45.8) 46.5 (45.0–48.0)
Age
0–4 years 28.9 (27.8–30.0) 36.7 (34.6–38.8)
5–9 years 22.0 (21.2–22.7) 27.9 (26.6–29.3)
10–14 years 21.3 (20.6–22.0) 18.2 (17.0–19.6)
15–19 years 27.8 (26.6–29.1) 17.1 (15.7–18.7)
Race/Ethnicity
White 48.4 (44.2–52.7) 55.7 (50.5–60.8)
Black 9.7 (8.4–11.2) 7.1 (5.7–8.7)
Hispanic 21.2 (17.7–25.3) 17.1 (13.6–21.3)
Asian/Pacific Islander 7.9 (6.7–9.4) 7.5 (6.0–9.4)
Primary Payer
Public 39.2 (36.7–41.9) 37.1 (34.2–40.0)
Private 53.4 (50.9–55.9) 57.3 (54.1–60.4)
Self-pay 2.2 (1.5–3.1) 2.4 (1.4–4.0)
Other 5.2 (3.9–6.9) 3.2 (2.5–4.2)
Mean Household Income per Zip Code
1st quartile 24.8 (22.5–27.3) 24.1 (20.7–27.8)
2nd quartile 25.3 (50.9–55.9) 25.1 (23.0–27.2)
3rd quartile 25.3 (1.5–3.1) 24.3 (22.2–26.6)
4th quartile 24.6 (21.8–27.6) 26.5 (22.6–30.8)
Type of Cancer
ALL 24.6 (23.5–25.8) 44.3 (41.6–47.0)
Bone Cancer 12.8 (12.0–13.6) 10.4 (9.1–12.0)
Central Nervous
System Tumor
9.6 (8.8–10.4) 6.2 (5.1–7.6)
AML 5.9 (5.5–6.3) 7.4 (5.9–9.1)
Soft Tissue Sarcoma 5.1 (4.7–5.6) 4.6 (3.9–5.4)
Neuroblastoma 4.5 (3.9–5.1) 4.7 (3.7–6.0)
Hodgkin Lymphoma 3.2 (2.9–3.5) 2.9 (2.5–3.4)
Wilms Tumor 2.7 (2.5–3.0) 3.0 (2.5–3.4)
Non-Hodgkin Lymphoma 2.6 (2.3–2.9) 3.6 (3.1–4.3)
Ovarian or Testicular
Tumor
1.7 (1.5–1.9) 0.7 (0.5–1.0)
Hospital Characteristics
Hospital Location-Teaching Status
Rural 1.7 (1.0–2.8) 1.6 (0.7–3.3)
Urban, non-teaching 9.9 (7.0–13.8) 7.2 (4.4–11.6)
Urban, teaching 88.4 (84.4–91.5) 91.2 (86.7–94.3)
Table 1 Characteristics of Discharges for Non-Transferred
Pediatric Cancer Patients: Overall and for Fever and Neutropenia
(FN) Discharges – United States, 2009 (Continued)
Proportion of Overall
Pediatric Cancer
Discharges
Proportion of
Pediatric FN
Discharges
% (95% CI)
Hospital Region
Northeast 16.3 (11.2–23.0) 20.7 (13.6–30.2)
Midwest 21.5 (15.7–28.8) 26.0 (18.0–36.0)
South 36.3 (28.6–44.8) 40.2 (29.7–51.8)
West 25.9 (18.8–34.4) 13.1 (7.4–22.2)
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Table 2 Comparison of Proportion of Infectious Diagnoses by LOS Category Among Pediatric Cancer FN Discharges
Overall LOS Category
“Short LOS” ≤3 days 4–7 days 8–14 days 15–30 days 31+ days
Proportion (%)
Proportion of FN DCs 41 33 16 7 3
No Infection Identified 75.9 82.7 77.3 66.9 62.8 44.4
Type of Infection
Upper Respiratory Infection 5.4 6.0 5.6 4.0 4.1 5.3
Acute Otitis Media 2.9 3.7 2.3 2.3 2.2 3.3
Bloodstream Infection 10.4 3.1 9.5 20.8 23.8 35.6
Viral Infection 2.3 3.1 2.3 1.6 0.2 0
Urinary Tract Infection 1.9 1.1 2.3 2.2 2.6 4.6
Pneumonia 1.1 0.3 0.6 2.3 4.1 6.8
Table 3 Mean Charges for Pediatric Cancer Fever and
Neutropenia Discharges: Overall and by Length of Stay
Category - United States, 2009
Mean Charges Total Charges
Overall $46,938 $528,052,500
Length of Stay Category
≤ 3 days – “Short LOS” $13,098 $60,538,956
4–7 days $30,092 $112,935,276
8–14 days $65,313 $115,604,010
15–30 days $149,780 $115,031,040
> 30 days $371,506 $124,826,016
Charges are adjusted to 2014 dollars using the Consumer Price
Index adjustment
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Table 4 Multivariate Logistic Regression to Evaluate Factors
Associated with a “Short LOS” (≤3 days) Among Pediatric Cancer
Fever and Neutropenia Discharges
Factors Adjusted
Odds Ratio
(OR)
95% CI p-value
Gender
Female 1.00 0.88–1.12 0.943
Age
15–19 years Ref
10–14 years 0.98 0.78–1.23 0.873
5–9 years 1.23 0.98–1.54 0.071
0–4 years 1.15 0.95–1.40 0.148
Primary Payer
Public Ref
Private 1.14 0.99–1.31 0.065
Self-pay 1.18 0.71–1.95 0.533
Other 1.30 0.93–1.82 0.125
Median Household Income per Zip Code
1st quartile Ref
2nd quartile 1.09 0.89–1.33 0.390
3rd quartile 1.09 0.91–1.31 0.334
4th quartile 1.11 0.9–1.37 0.316
Hospital Location-Teaching Status
Urban, teaching Ref
Urban, non-teaching 0.76 0.55–1.06 0.110
Rural 1.23 0.80–1.91 0.346
Hospital Region
Northeast Ref
Midwest 1.66 1.23–2.24 0.001
South 1.25 0.99–1.57 0.062
West 1.54 1.11–2.15 0.01
Type of Infection
Upper Respiratory Infection 1.12 0.90–1.40 0.294
Acute Otitis Media 1.39 1.03–1.87 0.031
Bloodstream Infection 0.17 0.14–0.22 <0.001
Viral Infection 1.63 1.18–2.25 0.003
Urinary Tract Infection 0.50 0.32–0.76 0.001
Pneumonia 0.28 0.13–0.60 0.001
Type of Cancer
ALL 0.94 0.77–1.13 0.492
Bone Cancer 1.24 0.98–1.58 0.075
Central Nervous System Tumor 1.06 0.81–1.39 0.651
AML 0.35 0.25–0.49 <0.001
Soft Tissue Sarcoma 1.46 1.05–2.04 0.024
Neuroblastoma 0.65 0.46–0.93 0.019
Hodgkin Lymphoma 2.32 1.61–3.35 <0.001
Table 4 Multivariate Logistic Regression to Evaluate Factors
Associated with a “Short LOS” (≤3 days) Among Pediatric Cancer
Fever and Neutropenia Discharges (Continued)
Factors Adjusted
Odds Ratio
(OR)
95% CI p-value
Wilms Tumor 1.26 0.84–1.89 0.260
Non-Hodgkin Lymphoma 0.73 0.52–1.01 0.061
Ovarian or Testicular Tumor 1.76 1.05–2.95 0.031
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